Clinical Trial Update: EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing dupilumab versus omalizumab in Type 2 inflammatory disease patients (chronic rhinosinusitis with nasal polyps and asthma) has completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• Dupilumab (Dupixent) (Dupilumab)
• Omalizumab (Xolair) (omalizumab)

Snippet

Sponsor: Sanofi | Conditions: Chronic Rhinosinusitis With Nasal Polyps, Asthma | Phase 4 | Status: COMPLETED | Results posted: 2025-10-23